Morishita Jintan Co., Ltd. (TYO:4524)

Market Cap	9.53B +10.6%
Revenue (ttm)	12.87B +1.9%
Net Income	560.00M +79.5%
EPS	136.79 +79.2%
Shares Out	4.10M
PE Ratio	17.00
Forward PE	n/a
Dividend	65.00 (2.83%)
Ex-Dividend Date	Mar 30, 2026

Volume	3,200
Average Volume	3,465
Open	2,308.00
Previous Close	2,294.00
Day's Range	2,302.00 - 2,326.00
52-Week Range	1,950.00 - 2,390.00
Beta	-0.05
RSI	50.16
Earnings Date	Feb 12, 2026

About Morishita Jintan

Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health foods in Japan. The company offers health food products, oral care product, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shop; domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200 and Bifidobacterium Pearl products through medical institutions. In ad...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 356
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4524

Financial Performance

In fiscal year 2025, Morishita Jintan's revenue was 12.77 billion, an increase of 2.90% compared to the previous year's 12.41 billion. Earnings were 547.00 million, a decrease of -21.52%.